Plasma NFL did not differ between Aβ-positive and Aβ-negative controls, suggesting that any neuronal injury that may have occurred in Aβ-positive controls (ie, preclinical AD) is below the detection limit for plasma NFL. This evidence concerns the gene NEFL and Alzheimer disease.